Skip to content
Precision for Medicine
Upcoming Webinar

Breaking Barriers with PCR: Innovative Solutions for Clinical Trial Success

iStock-1500823492 (1)

Rationaliser le démarrage de votre étude avec précision

Lancez vos essais cliniques avec efficacité et expertise.
Dans l'environnement actuel des essais cliniques, qui évolue rapidement, il est plus important que jamais d'initier votre étude de manière efficace. L'approche de Precision en matière de démarrage d'étude combine l'innovation technologique, la connaissance de la réglementation et l'expertise mondiale pour optimiser chaque phase de l'initiation de l'essai, garantissant ainsi que votre étude démarre avec l'élan nécessaire pour réussir.
iStock-1332002332 (1) (1)

Accélérer le démarrage de votre essai clinique

Les essais cliniques réussis commencent par un démarrage d'étude bien exécuté. En se concentrant sur la sélection stratégique des sites et la soumission rapide des demandes réglementaires, l'équipe mondiale de démarrage des études de Precision contribue à jeter les bases de résultats d'essais réussis dans les délais impartis. Notre équipe s'occupe de l'activation des sites avec précision en s'appuyant sur un personnel local spécialisé et sur un partenariat étroit avec notre département des affaires réglementaires. Grâce à cette synergie, nous rationalisons les soumissions en Amérique du Nord, en Europe et en Asie-Pacifique. Chaque étude présente ses propres défis, c'est pourquoi il est essentiel de travailler avec un personnel expérimenté qui se consacre à guider un démarrage d'étude efficace.
5 Nombre moyen d'années d'expérience dans la création d'entreprise
45 pays soutenus par l'équipe Start Up de Precision

Notre parcours éprouvé vers la réussite de la création d'une étude

Les services de démarrage d'études de Precision reposent sur une planification détaillée et une stratégie proactive. De l'identification des sites les plus appropriés dans le monde entier à la navigation dans les complexités des réglementations locales et mondiales, notre équipe veille à ce que votre étude soit lancée sans délai. En mettant l'accent sur la collaboration interfonctionnelle, la responsabilité et la gestion proactive des risques, nous nous associons à vous pour accélérer l'accès des patients à des thérapies qui changent la vie.
La voie de la précision

Perspectives d'experts de Precision

Découvrez les nouvelles perspectives et stratégies de nos experts à la pointe de la recherche clinique et translationnelle.

Read: Has the rest of the world finally caught up with Latin America? Has the rest of the world finally caught up with Latin America?

Clinical Trials

Has the rest of the world finally caught up with Latin America?

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=220405672474, hs_child_table_id=0, hs_updated_at=1788379304461, hs_published_at=1788379322226, description=Andrés Bayona, MD, MBA, is a tenured physician and healthcare executive with over 30 years of experience spanning clinical practice, healthcare management, and global clinical research operations. He holds a specialization in Internal Medicine, as well as advanced degrees in Health Services Management and an MBA. In his role as VP, Clinical Operations, his many years in CRO and global Pharma roles and deep connections within the Latin American healthcare industry make him uniquely qualified to guide our growth strategy in Latin America., avatar=Image{width=240,height=360,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Bayona_Andres_1445.jpg',altText='Bayona_Andres_1445',fileId=220973350833}, lastname=Bayona, hs_initial_published_at=1787769344448, hs_created_by_user_id=65712240, hs_created_at=1787769297292, hs_is_edited=false, hs_deleted_at=0, name=Andrés, job=Vice President, Clinical Operations, slug=andres-bayona, hs_updated_by_user_id=65712240}, second={}, third={}})
  • Andrés Bayona avatar

    Andrés Bayona

Découvrir
Read: Case Study: Rapid Execution of Assay Validation Rescued Global Study Case Study: Rapid Execution of Assay Validation Rescued Global Study

Translational Research - Assays

Case Study: Rapid Execution of Assay Validation Rescued Global Study

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=219184495938, hs_child_table_id=0, hs_updated_at=1786473626295, hs_published_at=1788379322226, description=Christie Bongel is a scientist by training, but her true passion lies in leadership, particularly in building leaders and shaping high-performing, trust-based cultures. She believes that many talented bench scientists are promoted into management roles without formal leadership development and is committed to helping close that gap. While culture and people development may not always appear on a balance sheet, she views them as essential drivers of long-term organizational success. As a leadership-focused operations executive, Christie leads laboratory operations and strategy within a global network, partnering with pharmaceutical and biotechnology organizations to navigate complex oncology challenges. Her work spans translational oncology, clinical trial strategy, and laboratory execution, with a focus on translating scientific and operational complexity into clear, actionable strategies that drive meaningful outcomes., avatar=Image{width=800,height=800,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/1781614819314.png',altText='Christie Bongel',fileId=219203862915}, lastname=Bongel, hs_initial_published_at=1786473638412, hs_created_by_user_id=65712240, hs_created_at=1786473568408, hs_is_edited=false, hs_deleted_at=0, name=Christie, job=Site Director, slug=christie-bongel, hs_updated_by_user_id=65712240}, second={hs_id=159488778874, hs_child_table_id=0, hs_updated_at=1765824406763, hs_published_at=1788379322226, description=Kennon Daniels is a scientific and regulatory in vitro diagnostic authority, specializing in the development of US regulatory strategies and FDA marketing submissions for IVD assays and instruments. Her expertise spans all aspects of product development, analytical and clinical trial protocol designs, Q-Submissions, IDEs, de novos, 510(k)s, and pre-market approval platforms., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Kennon%20Daniels.webp',altText='Kennon Daniels',fileId=165893120790}, linkedin=https://www.linkedin.com/in/kennon-daniels-ph-d-84a90b6, hs_name=, hs_path=, lastname=Daniels, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745105, hs_is_edited=false, hs_deleted_at=0, name=Kennon, position=Vice President, IVD Regulatory Consulting, job=, slug=kennon-daniels, email=, hs_updated_by_user_id=65712240}, third={}})
  • Christie B. avatar

    Christie B.

  • Kennon D. avatar

    Kennon D.

Découvrir
Read: Clinical AI at Scale: Why Trust Matters More Than Speed Clinical AI at Scale: Why Trust Matters More Than Speed

Clinical Trials

Clinical AI at Scale: Why Trust Matters More Than Speed

|
    has third author: false, (SizeLimitingPyMap: {main={hs_id=219402396746, hs_child_table_id=0, hs_updated_at=1787057935787, hs_published_at=1788379322226, description=Zulfat Kapadia is a Statistical Programmer with a scientist's heart and a programmer's precision, bringing over 11 years of experience in clinical data analytics. She currently works as a Statistical Programmer at Precision for Medicine, focusing on clinical data transformations and safety analytics. She is a SAS-certified Statistical Programmer with strong expertise in CDISC standards (SDTM and ADaM), turning raw clinical data into clean, submission-ready datasets and TLFs (Tables, Listings, and Figures). Her journey began with an M.Sc. in Microbiology from Gujarat University, followed by years as a Research Associate, where she worked hands-on with method development, validation, and LC-MS/MS analysis in GLP-regulated labs, including navigating regulatory audits. She later moved into SAS programming at Cognizant, building the technical foundation for her current specialization. A resourceful team player, she continues expanding her expertise across clinical and pharmaceutical domain., avatar=Image{width=1024,height=1536,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Zulfat%20Headshot.jpg',altText='Zulfat Headshot',fileId=219402357006}, lastname=Kapadia, hs_initial_published_at=1786648737451, hs_created_by_user_id=65712240, hs_created_at=1786648684030, hs_is_edited=false, hs_deleted_at=0, name=Zulfat, job=Statistical Programmer, slug=zulfat-kapadia, hs_updated_by_user_id=65712240}, second={hs_id=219402396744, hs_child_table_id=0, hs_updated_at=1786648683717, hs_published_at=1788379322226, description=As Principal Statistical Programmer, Shakila plays a key role in leading statistical programming activities for clinical development programs at Precision for Medicine. She has extensive experience managing study deliverables, supporting regulatory submissions, implementing CDISC standards, and collaborating with cross-functional teams to ensure high-quality and compliant clinical data outputs. Prior to joining Precision for Medicine, she held programming roles at ICON and Quintiles, where she contributed to global clinical trials across Oncology, Cardiovascular, Vaccine, and Diabetes therapeutic areas. She has led the development and validation of SDTM, ADaM, TLFs, define.xml, and submission-ready datasets for major health authorities including the FDA, PMDA, and EMEA. Beyond her expertise in SAS programming and clinical data standards, Shakila is passionate about process improvement, automation, and mentoring teams. She has recently expanded her capabilities in Data Science, gaining practical experience in Python, Machine Learning, R, and Tableau, and is keen on leveraging modern analytics and AI-driven approaches to enhance clinical research solutions., avatar=Image{width=1024,height=1536,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Shakila%20J%20Headshot.png',altText='Shakila J Headshot',fileId=219402114740}, lastname=Jagadeesan , hs_initial_published_at=1786648737451, hs_created_by_user_id=65712240, hs_created_at=1786648634345, hs_is_edited=false, hs_deleted_at=0, name=Shakila, job=Principal Statistical Programmer , slug=Shakila-Jagadeesan, hs_updated_by_user_id=65712240}, third={hs_id=219402097154, hs_child_table_id=0, hs_updated_at=1786648633237, hs_published_at=1788379322226, description=As Senior Manager of Statistical Programming, Sugumaran brings a wealth of experience to his role at Precision for Medicine, since March 2021. Prior to Precision for Medicine, he was associated with ICON Clinical Research for over 10 years across various roles in statistical programming. He has been actively involved in leading large and complex submissions for a diverse client base including large biopharma, biotech, and CROs. In addition to building his expertise in statistical programming, data analytics, and data visualization, he is deeply passionate about developing talent and cutting-edge software solutions. He is also actively involved with several social causes and CSR activities. Sugumaran holds an MBA in Pharmaceutical Management and a Master's in Bioinformatics. He is also currently pursuing a PhD in Bioinformatics., avatar=Image{width=1024,height=1536,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Sugumaran%20headshot.png',altText='Sugumaran headshot',fileId=219402130472}, lastname=Muthuraj, hs_initial_published_at=1786648737451, hs_created_by_user_id=65712240, hs_created_at=1786647962706, hs_is_edited=false, hs_deleted_at=0, name=Sugumaran, job=Senior Manager, Statistical Programming , slug=Sugumaran-Muthuraj, hs_updated_by_user_id=65712240}})
  • Zulfat K. avatar Shakila J. avatar Sugumaran M. avatar
  • Zulfat K.

    Shakila J.

    Sugumaran M.

Découvrir
  • Discover L'excellence en phase initiale
    82 (1)

    L'excellence en phase initiale

    Lancez-vous dans les premières étapes critiques de la découverte clinique avec nos essais de phase précoce gérés par des experts, où l'attention méticuleuse rencontre la stratégie innovante.

    Explorer
  • Discover Succès de la phase tardive
    phase tardive

    Succès de la phase tardive

    Découvrez le chemin vers le marché grâce à notre expertise en matière de développement de phase tardive - en apportant précision, échelle et efficacité à votre parcours clinique.

    Explorer

Une expérience approfondie des maladies débilitantes et des modalités uniques

Comme vous, nous comprenons qu'il y a un patient tout au long du parcours de développement. Notre objectif est d'aider nos partenaires à mettre des traitements innovants à la disposition des patients. Tirez parti de notre expérience dans ces domaines thérapeutiques.

Des capacités spécialisées à chaque étape du développement clinique

Tirer parti d'une infrastructure intégrée qui réduit les inefficacités inhérentes à un développement complexe. Intégrer l'exécution des laboratoires et des essais pour accélérer la mise sur le marché. Precision peut personnaliser et faire converger ses capacités pour répondre aux besoins uniques de votre programme, ce qui favorise l'efficacité, l'agilité et la réussite du début à la fin.

  • Discover Explorer
    soutien aux essais cliniques

    CRO mondial
    Services

    CRO primé avec une grande expertise en oncologie et en maladies rares

    Explorer
  • Discover Explorer
    Services de laboratoire spécialisés

    Laboratoire mondial
    Services

    Des sciences translationnelles et des sciences des biomarqueurs exceptionnelles avec des services de laboratoire central à l'échelle mondiale

    Explorer